AIMS: To investigate the impact of CCND1 and EFEMP1 gene polymorphism, and additional their gene-gene interactions and haplotype within EFEMP1 gene on glioma risk based on Chinese population. METHODS: Logistic regression was performed to investigate association between single-nucleotide polymorphisms (SNP) and glioma risk and generalized multifactor dimensionality reduction (GMDR) was used to analyze the gene-gene interaction. RESULTS: Glioma risks were higher in carriers of homozygous mutant of rs603965 within CCND1 gene, rs1346787 and rs3791679 in EFEMP1 gene than those with wild-type homozygotes, OR (95%CI) were 1.67 (1.23-2.02), 1.59 (1.25-2.01) and 1.42 (1.15-1.82), respectively. GMDR analysis indicated a significant two-locus model (p=0.0010) involving rs603965 within CCND1 gene and rs1346787 within EFEMP1 gene. Overall, the cross-validation consistency of the two- locus models was 10\ 10, and the testing accuracy is 60.17%. Participants with rs603965 - GA or AA and rs1346787- AG or GG genotype have the highest glioma risk, compared to participants with rs603965 - GG and rs1346787- AA genotype, OR (95%CI) was 3.65 (1.81-5.22). We conducted haplotype analysis for rs1346787 and rs3791679, because D' value between rs1346787 and rs3791679 was more than 0.8. The most common haplotype was rs1346787 - A and rs3791679- G haplotype, the frequency of which was 0.4905 and 0.4428 in case and control group. CONCLUSIONS: Polymorphism in rs603965 within CCND1 gene and rs1346787 within EFEMP1 gene and its gene- gene interaction were associated with increased glioma risk.
AIMS: To investigate the impact of CCND1 and EFEMP1 gene polymorphism, and additional their gene-gene interactions and haplotype within EFEMP1 gene on glioma risk based on Chinese population. METHODS: Logistic regression was performed to investigate association between single-nucleotide polymorphisms (SNP) and glioma risk and generalized multifactor dimensionality reduction (GMDR) was used to analyze the gene-gene interaction. RESULTS:Glioma risks were higher in carriers of homozygous mutant of rs603965 within CCND1 gene, rs1346787 and rs3791679 in EFEMP1 gene than those with wild-type homozygotes, OR (95%CI) were 1.67 (1.23-2.02), 1.59 (1.25-2.01) and 1.42 (1.15-1.82), respectively. GMDR analysis indicated a significant two-locus model (p=0.0010) involving rs603965 within CCND1 gene and rs1346787 within EFEMP1 gene. Overall, the cross-validation consistency of the two- locus models was 10\ 10, and the testing accuracy is 60.17%. Participants with rs603965 - GA or AA and rs1346787- AG or GG genotype have the highest glioma risk, compared to participants with rs603965 - GG and rs1346787- AA genotype, OR (95%CI) was 3.65 (1.81-5.22). We conducted haplotype analysis for rs1346787 and rs3791679, because D' value between rs1346787 and rs3791679 was more than 0.8. The most common haplotype was rs1346787 - A and rs3791679- G haplotype, the frequency of which was 0.4905 and 0.4428 in case and control group. CONCLUSIONS: Polymorphism in rs603965 within CCND1 gene and rs1346787 within EFEMP1 gene and its gene- gene interaction were associated with increased glioma risk.
Authors: A M L Bedewy; M H Mostafa; A A Saad; S M El-Maghraby; M M L Bedewy; A M Hilal; L S Kandil Journal: J BUON Date: 2013 Jan-Mar Impact factor: 2.533
Authors: Aga Syed Sameer; Fazl Q Parray; Manzoor Ahmad Dar; Saniya Nissar; Mujeeb Zafar Banday; Sabha Rasool; G M Gulzar; Nissar A Chowdri; Mushtaq A Siddiqi Journal: Mol Med Rep Date: 2013-01-24 Impact factor: 2.952
Authors: Yuanjie Hu; Peter Dion Pioli; Eric Siegel; Qinghua Zhang; Jodi Nelson; Abhishek Chaturbedi; Marlon S Mathews; Daniel I Ro; Selma Alkafeef; Nelson Hsu; Mark Hamamura; Liping Yu; Kenneth R Hess; Bruce J Tromberg; Mark E Linskey; Yi-Hong Zhou Journal: Mol Cancer Date: 2011-09-28 Impact factor: 27.401
Authors: Nicola J Armstrong; Karen A Mather; Muralidharan Sargurupremraj; Maria J Knol; Rainer Malik; Claudia L Satizabal; Lisa R Yanek; Wei Wen; Vilmundur G Gudnason; Nicole D Dueker; Lloyd T Elliott; Edith Hofer; Joshua Bis; Neda Jahanshad; Shuo Li; Mark A Logue; Michelle Luciano; Markus Scholz; Albert V Smith; Stella Trompet; Dina Vojinovic; Rui Xia; Fidel Alfaro-Almagro; David Ames; Najaf Amin; Philippe Amouyel; Alexa S Beiser; Henry Brodaty; Ian J Deary; Christine Fennema-Notestine; Piyush G Gampawar; Rebecca Gottesman; Ludovica Griffanti; Clifford R Jack; Mark Jenkinson; Jiyang Jiang; Brian G Kral; John B Kwok; Leonie Lampe; David C M Liewald; Pauline Maillard; Jonathan Marchini; Mark E Bastin; Bernard Mazoyer; Lukas Pirpamer; José Rafael Romero; Gennady V Roshchupkin; Peter R Schofield; Matthias L Schroeter; David J Stott; Anbupalam Thalamuthu; Julian Trollor; Christophe Tzourio; Jeroen van der Grond; Meike W Vernooij; Veronica A Witte; Margaret J Wright; Qiong Yang; Zoe Morris; Siggi Siggurdsson; Bruce Psaty; Arno Villringer; Helena Schmidt; Asta K Haberg; Cornelia M van Duijn; J Wouter Jukema; Martin Dichgans; Ralph L Sacco; Clinton B Wright; William S Kremen; Lewis C Becker; Paul M Thompson; Thomas H Mosley; Joanna M Wardlaw; M Arfan Ikram; Hieab H H Adams; Sudha Seshadri; Perminder S Sachdev; Stephen M Smith; Lenore Launer; William Longstreth; Charles DeCarli; Reinhold Schmidt; Myriam Fornage; Stephanie Debette; Paul A Nyquist Journal: Stroke Date: 2020-06-10 Impact factor: 7.914